“Microplastic particles are currently found almost everywhere – in water, food, fish, and even breast milk,” says Artūras Torkelis, a PhD student at Kaunas University of Technology (KTU). He emphasises that proper waste management is essential for reducing these risks.

Dana-Farber Cancer Institute (Boston, MA, USA) and Gustave Roussy (Grand Paris, Villejuif, France) have announced that the Fourth Transatlantic Exchange in Oncology Conference topic will be “Radiopharmaceutical Therapy Meets Oncology.” The meeting, supported by L'Institut Servier, will be held in-person on March 19, 2025, at Hyatt Regency Etoile Hotel and livestreamed.

Results of a VHIO-led study underscore the potential of the RAD51 biomarker in tailoring treatment strategies in patients with early breast cancer. 

This work reveals a new mechanism by which brown fat is converted into heat, and which protects from pathologies associated with obesity.

The MCJ protein is key to the fat burning mechanism now identified, making it a promising target for treating obesity, according to the authors in Nature Communications.

The research is led by Guadalupe Sabio, from Spain’s National Cancer Research Centre (CNIO), and Cintia Folgueira, from both CNIO and the National Centre for Cardiovascular Research (CNIC).

Scientists have struggled for decades to understand why radiation therapy kills cells from the same tumour in different ways. This is important because some forms of cell death are unnoticed by the immune system, while others trigger an immune response. Unleashing the patient’s immune system to clear tumours is a major goal of cancer treatment. This new research, published in Nature Cell Biology, reveals for the first time how DNA repair, which normally protects healthy cells, determines how cancer cells die following radiotherapy.